2019 Hospital and Internal Medicine Forum – LA

Saturday, June 15, 2019
7:30 AM – 4:15 PM
Torrance Marriott Redondo Beach
3635 Fashion Way
Torrance, CA 90503

 

Program Overview

The 2019 Hospital and Internal Medicine Forum (HIMF) is an innovative, multi-supported, multifaceted educational initiative designed for hospital-based and internal medicine clinicians (physicians, physician assistants, nurse practitioners, pharmacists, and nurses). The program aims to provide important educational updates from leading experts on conditions that are commonly encountered by healthcare clinicians practicing in the hospital and various internal medicine settings.

HIMF is the premier regional meeting series for hospital- and internal medicine-based clinicians. It offers an exceptional educational experience delivered by nationally-renowned faculty. Participants will gain essential medical knowledge and be updated on recent advances in patient care, both within hospital medicine and across the broader discipline of internal medicine.

What’s new at HIMF in 2019?

The Hospital Medicine Summit has been rebranded to Hospital and Internal Medicine Forum such that it is more representative of clinicians in hospitals and large health systems and whose practice encompasses both hospital and clinic settings.

Learning Labs consisting of interactive patient studies and role-play activities on key topics to provide practical and patient-centered approaches to overcome common obstacles in patient care

Meet the Professor. Distinguished faculty will be available during the morning and afternoon breaks to address learners’ questions surrounding controversial issues, recent advances, and new developments in selected topics.

Program Agenda

7:30 AM – 8:00 AM Registration/Breakfast
8:00 AM – 9:00 AM Keynote: Combatting Burnout in the Increasingly Demanding Hospital and Health-system Environment
Alpesh Amin, MD, MBA
9:00 AM – 10:15 AM Optimizing the Management of Heart Failure from Hospital to Home: Translating the Latest Evidence into Practice
Barry Greenberg, MD
10:15 AM – 10:45 AM Break
10:45 AM – 12:00 PM Hepatic Encephalopathy: Achieving Care Goals in the Acute Setting and Beyond
Robert Rahimi, MD, MSCR
12:00 PM – 1:00 PM Lunch Poster Reception
1:00 PM – 2:15 PM Achieving Optimal COPD Management through Individualized Treatment and Device Selection
Nicola Hanania, MD, MS
2:15 PM – 2:30 PM Break
2:30 PM – 3:00 PM
Interactive Learning Labs
3:00 PM – 4:15 PM Individualizing Management of T2DM in the Hospital Setting to Reduce Macro and Microvascular Complications
Alpesh Amin, MD, MBA
4:15 PM Closing Remarks/Meeting Adjournment

 

Target Audience

This educational initiative has been designed for physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists who practice in hospital and internal medicine settings.

Learning Objectives

Keynote Session

  • Discuss the causes of burnout in hospital- and internal medicine-based practice
  • Describe strategies to overcome burnout
  • Review strategies designed to address burnout in a team-based healthcare environment

Heart Failure Session

  • Assess the type, stage, and functional classification of heart failure (HF) in hospitalized patients
  • Develop a patient-centered, guideline-directed, evidence-based management plan for patients hospitalized with heart failure with reduced ejection fraction
  • Integrate data on newer agents approved for heart failure with reduced ejection fraction to ensure safe and appropriate administration in patients shortly after an acute episode
  • Summarize the FDA recall of common heart failure medications and which agents have and have not been recalled
  • Apply effective transitions of care strategies for the management of patients with HF

Hepatic Encephalopathy Session

  • Identify symptoms and risk factors of Hepatic Encephalopathy (HE) and approaches to diagnosis that are concordant with current guidelines recommendations
  • Utilize available clinical and observational data to design effective acute and prophylactic treatment regimens for patients with HE
  • Implement transitional and long-term care strategies to reduce rehospitalization in patients with HE

COPD Session

  • Describe an approach to chronic obstructive pulmonary disease (COPD) treatment that is consistent with current evidence-based guideline recommendations
  • Review the efficacy, safety, and utility of available therapies for the long-term management of COPD
  • Match patients with appropriate COPD medication delivery devices

COPD Learning Lab:
Available COPD Delivery Devices Review

  • Review available drug delivery devices for long-term management of COPD
  • Identify device attributes and device-specific considerations for patient education and device training

HF Learning Lab:
Optimizing Transitions of Care for Patients with Heart Failure

  • Describe best practices for optimal transition of patients with HF from acute-care to outpatient settings
  • Develop patient education plans that engage patients and patient family members
  • Identify appropriate follow-up strategies for patients with HF post-discharge

Diabetes Session

  • Summarize correlations between macro and microvascular complications of uncontrolled T2DM and hospitalization
  • Evaluate the risk/benefit profiles of novel T2DM therapies in achieving glycemic control and reducing vascular complications
  • Employ evidence-based strategies to individualize treatment for diverse patients with T2DM to achieve glycemic control and reduce hospitalizations from vascular complications

Disclosures

A detailed disclosure for all persons in control of content, including faculty presenters, will be provided at the live event.

Accreditation

Physician Continuing Education

Accreditation Statement

Integrity Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
Integrity Continuing Education designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Pharmacist Continuing Education

Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Global Education Group designates this continuing education activity for 6.5 contact hours (0.65 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Numbers – 0530-9999-19-076-L01-P, 0530-9999-19-077-L01-P, 0530-9999-19-078-L01-P, 0530-9999-19-079-L01-P, 0530-9999-19-080-L01-P, 0530-9999-19-081-L01-P, 0530-9999-19-082-L01-P)

This is a knowledge-based activity.

Nursing Continuing Education

Accreditation Statement
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation
This educational activity for 6.5 contact hours is provided by Global Education Group.

Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the evaluation in its entirety. Pharmacists must check the CPE Monitor for credits within 60 days of the activity.

Contact Information

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or himf@integrityce.com.

For information about ACPE or ANCC accreditation of this activity, please contact Global at (303) 395-1782 or cme@globaleducationgroup.com.

Americans with Disabilities Act

Event staff will be glad to assist you. Please contact Integrity Continuing Education prior to the live event at (855) 835-4004.

Disclosure of Conflicts of Interest (COI)

Integrity Continuing Education and Global Education Group requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education and Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education and Global Education Group do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

There is no cost to attend.

Provider Statement

This CME activity is provided by Integrity Continuing Education.
This CE activity is jointly provided by Global Education Group and Integrity Continuing Education.

Supporter Acknowledgement

This activity is supported by independent educational grants from Novartis Pharmaceuticals Corporation, Salix, a division of Valeant Pharmaceuticals North America LLC, and Sunovion Pharmaceuticals, Inc.

Agenda

7:30 AM – 8:00 AM Registration/Breakfast
8:00 AM – 9:00 AM Keynote: Combatting Burnout in the Increasingly Demanding Hospital and Health-system Environment
Alpesh Amin, MD, MBA
9:00 AM – 10:15 AM Optimizing the Management of Heart Failure from Hospital to Home: Translating the Latest Evidence into Practice
Barry Greenberg, MD
10:15 AM – 10:45 AM Break
10:45 AM – 12:00 PM Hepatic Encephalopathy: Achieving Care Goals in the Acute Setting and Beyond
Robert Rahimi, MD, MSCR
12:00 PM – 1:00 PM Lunch Poster Reception
1:00 PM – 2:15 PM Achieving Optimal COPD Management through Individualized Treatment and Device Selection
Nicola Hanania, MD, MS
2:15 PM – 2:30 PM Break
2:30 PM – 3:00 PM
Interactive Learning Labs
3:00 PM – 4:15 PM Individualizing Management of T2DM in the Hospital Setting to Reduce Macro and Microvascular Complications
Alpesh Amin, MD, MBA
4:15 PM Closing Remarks/Meeting Adjournment